Deep
Saturday, August 22, 2026
24.1
C
Bengaluru
Hot topics
Will Omicron Wave be a Repeat Rx for Indian Pharma?
How had Indian Pharma responded to the challenges brought on by the Covid19 crisis and the inability to connect with doctors and other Rx influencers?
Is it back to business-as-usual or have some companies learned from their mistakes and become digital savvy?
How will Indian Pharma cope with the possibility of another lockdown and meeting restrictions looming in view of the rising Omicron wave?
American Tariffs and The Rise of the Corporate Superpower
From Nation-States to Corporate Titans: How Innovation is Redrawing...
Can Medicines Inject the Vitamins Amazon is Missing?
How Amazon’s Healthcare Bet May Change Indian Diagnostics and...
Interesting, Engaving & Relevant
In this issue Deepak Sharma talks about his journey from Medical Rep to Country Manager. Deeksha Fouzdar presents a case study on implementation of a competency-based HR system in Pharma. Other articles by K. Hariram and Vivek Hattangadi
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Hot topics
How a Delhi Dementia Daycare Is Reimagining Care for India’s Forgotten Millions
By MedicinMan Editorial Desk
When Memory Fades, Humanity Must Not
In...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Boehringer Ingelheim India focuses on partnerships in NCD management
Addressing the media at a roundtable this morning, Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five multinational pharmaceutical companies in India over the next few years. We have been enabling access to our innovator products to patients across India and the neighbouring markets in the diabetes, cardiovascular, stroke and respiratory diseases segments. Our plan in these therapy areas is to build sustainable partnerships to ensure an ecosystem of access and care for patients. We have initiated action in that direction.”
Digital as Emergent Strategy – Lessons for Pharma from Honda
The door to the magical realm is open! Are...
Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.
Manishkumar Munot has joined Biological E. Limited as Chief...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Newsletter
Get important news delivered directly to your inbox and stay connected!